Latest Posts

CMS announced a finalized rule updating oversight of organ procurement organizations, aiming to improve accountability and help more donated organs reach patients awaiting transplants. The agency said the policy has implications for Medicare and Medicaid program administration and is intended to strengthen performance expectations for these organizations. The announcement frames the rule as part of broader efforts to improve transplant access and outcomes through tighter federal standards.

The Iowa City VA Health Care System announced a new medical center director. As a leadership change within a federal health system, the announcement is relevant to administration and oversight of VA healthcare delivery in the region. The notice identifies a transition in senior management rather than a new funding or policy initiative.

CMS issued a final rule on October 30, 2026 revising the conditions for coverage for organ procurement organizations. The agency says the rule updates policies on recertification, competition, appeals, and oversight, aiming to strengthen accountability and patient protections in organ procurement. This appears materially distinct from the earlier published post about a proposed rule because it covers the final rule and its adopted policy changes.

CMS's fact sheet on plan year 2027 outlines HealthCare.gov plan availability, premiums, plan choice, and open enrollment information for consumers shopping for individual-market coverage. The document highlights how many plan options are available and summarizes pricing trends relevant to affordability and consumer choice. It serves as a current snapshot of what enrollees can expect when comparing 2027 Marketplace coverage.

CMS announced $39.7 million in Rural Health Transformation Program funding for Missouri providers. According to the agency, the awards will support expansion of maternal, behavioral, diagnostic, outpatient, and chronic disease services in rural communities. The funding is presented as part of a federal effort to modernize care delivery and increase access closer to home.

CMS announced more than $19 million in Rural Health Transformation Program awards for West Virginia. The agency said the funding will support telehealth, specialty care, mobile health, workforce training, and health IT modernization across the state. The announcement highlights a mix of service expansion and infrastructure investment targeted at rural healthcare capacity.

KFF’s 2026 employer survey reports new data on cost-sharing in employer-sponsored coverage, including hospital admission and outpatient surgery charges, deductibles, and affordability pressures facing workers and families. The findings add a current employer-market view of health care cost exposure that is distinct from Medicare and Medicaid payment policy updates. It is also different from the previously published consumer affordability post because it centers on employer plan design and enrollee cost-sharing trends.

CMS announced more than $233 million in Rural Health Transformation Program funding for California on October 29, 2026. According to the agency, the funding is intended to expand rural primary care, maternal health, specialty services, behavioral health, telehealth, and workforce capacity. The announcement frames the investment as part of a broader effort to improve access to care in rural communities across the state.

The Department of Veterans Affairs said it plans to hire more than 2,000 employees to help process a growing volume of Veteran claims. The announcement ties the hiring push to system capacity and service delivery demands as claims workloads increase. It signals a staffing response aimed at maintaining or improving timeliness in benefits processing.

CMS finalized the CY 2027 ESRD payment rule, updating Medicare payment for dialysis services and related care. The fact sheet highlights a dialysis base-rate increase, the incorporation of phosphate binder costs into the ESRD bundled payment, and other payment adjustment changes affecting providers and program spending. The rule is materially focused on kidney care payment policy rather than the broader Medicare payment and pricing items already covered.

CMS announced more than $193 million in Rural Health Transformation Program funding for Florida on October 28, 2026. The agency said the funding will support preventive care, expand specialty access, strengthen telehealth, and improve rural service delivery. The announcement highlights the funding as a step toward reducing travel and access barriers for people seeking care in rural parts of the state.

The Justice Department announced that dialysis centers agreed to pay $2 million to resolve allegations involving fraud tied to Provider Relief Fund payments. According to the press release, the case centers on alleged misuse of federal pandemic relief funds intended to support healthcare providers. The settlement adds to ongoing federal healthcare-fraud enforcement focused on pandemic-era funding and provider billing compliance.

The Federal Register public inspection version provides the formal regulatory text and rationale for CMS's proposed Exchange pre-eligibility verification rule. It describes new eligibility and verification requirements tied to premium tax credit and cost-sharing reduction determinations, offering the detailed legal framework behind the policy changes outlined by CMS. For coverage policy watchers, this document is the key source for the proposal's exact requirements and implementation approach.

KFF updated this brief with October 2026 polling on medical bills, skipped care, and affordability concerns, providing a current snapshot of how health care costs affect households. The findings focus on consumer experience and financial strain, which is materially different from previously published items centered on Medicare payment rules, Medicaid oversight, or administrative reforms. It is a timely public-interest update on cost burdens facing patients directly.

CMS announced a $275 million nationwide initiative with states to support nurse recruitment and retention in nursing homes. The funding comes from CMS and state civil monetary penalty dollars and is aimed at Medicare- and Medicaid-certified facilities. The program focuses on strengthening staffing in nursing homes through state-based efforts to attract and keep nurses.

CMS released a fact sheet on a proposed rule that would require Health Insurance Exchanges to verify eligibility criteria before providing advance premium tax credits and cost-sharing reductions. The proposal directly affects when subsidy payments are made and is aimed at improving payment accuracy and program integrity in coverage affordability programs. Because the topic centers on pre-eligibility checks for Exchange subsidies rather than Medicare, Medicaid managed care, or pricing transparency, it is materially different from the titles already published.

A Unified Agenda entry shows HHS planning updates to its Privacy Act regulations, including changes affecting access to medical records and removal of duplicative FDA privacy regulations. The item signals forthcoming rulemaking that could alter how individuals access records and how HHS aligns agency privacy rules. It is distinct from previously published privacy and FDA software posts because it centers on departmentwide Privacy Act regulatory revisions rather than data-sharing ethics or device-related guidance.

CMS announced a Georgia Rural Health Transformation Program award of nearly $219 million. According to the announcement, the funding will support rural workforce expansion, telehealth, mobile care, and hospital technology modernization. The award is intended to strengthen care delivery capacity in rural parts of Georgia through staffing and technology investments.

CMS issued a request for information on increasing health care resiliency that explicitly addresses ransomware, cyberattacks, patient data protection, and safeguarding health information across digital infrastructure. The notice frames privacy as part of operational resilience in the health sector, linking continuity of care with stronger protection for sensitive patient data. It is materially distinct from previously covered FDA software and health AI items because it focuses on systemwide resiliency and protection of health information from cyber threats.

This KFF chart collection updates federal actuaries’ projections for U.S. health spending growth and highlights expected trends across hospitals, prescription drugs, and out-of-pocket costs. It offers a forward-looking view of cost pressures affecting households and public programs, making it a distinct addition to the topic beyond prior posts on specific CMS payment rules or reports to Congress. The source is especially relevant for readers tracking broader national cost trends rather than a single policy change.

DOJ and HHS announced on October 22 a six-month pilot program inviting healthcare companies to voluntarily self-disclose potential False Claims Act violations. The program is aimed at strengthening anti-fraud enforcement while creating a structured pathway for providers and companies to report misconduct. As a federal enforcement initiative involving major health agencies, it is a notable healthcare politics development with implications for compliance, oversight, and administration priorities.

CMS's October 22, 2026 MLN Connects newsletter included new provider guidance on dual-eligible billing and cost-sharing protections. The guidance addresses situations in which Medicaid coverage is lost under the Working Families Tax Cut legislation. This update is aimed at helping providers bill correctly and apply beneficiary protections when coverage status changes.

VA reported that more than 300,000 new veterans enrolled in VA healthcare in 2026 following major reforms. The announcement also included data on appointments and access to care, indicating broader use of VA services alongside the enrollment gains. The update highlights increased participation in VA healthcare and the department's reported access metrics for the year.

The New York State Department of Health page for hospital administrator letters lists an October 20, 2026 directive concerning the electronic health record law for organ donation registration. This appears to be a state-level health law implementation item for hospitals, focused on operational compliance with organ donation registration requirements in EHR systems. It is materially different from the previously covered federal proposed rule on organ procurement organization oversight.

The Justice Department announced on October 20, 2026 that it reached an agreement with Mount Sinai resolving a federal investigation into the health system’s provision of pediatric gender-related care. The matter is framed as a healthcare enforcement action involving federal legal authority and patient-treatment policy. The agreement appears materially distinct from the previously published law-topic items, which focused on fraud, antitrust, billing, device regulation, and data privacy rather than this type of federal intervention in clinical practice.

KFF updated its polling dashboard on October 20 with new data on public trust in the CDC, FDA, state health officials, HHS Secretary Robert F. Kennedy Jr., and President Trump. The findings add fresh insight into how Americans view government health authorities and how those views vary across partisan lines. The update is relevant to healthcare politics because trust in public institutions can shape public response to health policy, regulation, and official guidance.

The White House issued an executive order on October 19, 2026 creating a Women’s Health Task Force and setting a new administration-wide policy framework on women’s health. The order also revokes prior Biden-era women’s health actions, making it a clear shift in federal healthcare policy direction through executive action. As a politics story, it centers on how the administration is redefining priorities and coordination across the federal government.

CMS announced more than $16 million for Maryland on October 19, 2026 to strengthen rural healthcare workforce training and retention. The funding will support apprenticeships and practical supports such as tuition, transportation, and uniforms, which can reduce barriers for people entering or staying in rural healthcare jobs. By building a more stable local workforce, the initiative is intended to improve access to care in underserved communities.

CMS proposed changes for Medicare Advantage and Part D on October 16, 2026 that would tighten provider-directory accuracy requirements and strengthen enrollee protections. For patients, especially those relying on network information to find in-network care, the proposal targets a common access problem: inaccurate directories that can delay treatment or lead to unexpected costs. The announcement also frames the reforms as part of a broader effort to improve transparency and affordability in Medicare coverage.

CMS released a fact sheet on a proposed rule that would reduce generic drug copayments from $1 to $0 for certain full-benefit dual eligibles in Part D and add pharmacy benefit manager accountability provisions. The proposal is directly relevant to beneficiary affordability and plan oversight, with a narrower focus than previous broad drug-cost or Medicare reform posts. If finalized, the change would eliminate a small but recurring out-of-pocket charge for some low-income enrollees.

CMS announced $92 million for Ohio on October 16, 2026 to help coordinate rural hospital networks and expand access to key services. The funding is intended to bring services such as MRI, behavioral health, and maternal care closer to patients while improving how rural providers connect and share resources. The announcement points to a broad access strategy focused on reducing travel burdens and strengthening service availability across rural communities.

CMS announced more than $11 million for New Hampshire through the Rural Health Transformation Program on October 16, 2026. The funding is aimed at strengthening rural EMS partnerships and expanding mobile integrated healthcare so patients in underserved areas can receive more services closer to home. The initiative directly addresses access barriers tied to distance, emergency response capacity, and limited local service availability.

CMS announced new rural-health funding for Montana on October 16, 2026 to expand rural EMS and community integrated health services. According to the announcement, the investment will support more in-home and community-based care delivery, helping patients access services without traveling long distances. The funding is intended to reduce rural access gaps caused by geography and limited provider availability.

MedPAC’s Payment Basics overview explains how accountable care organization payment systems work and how they shape Medicare spending incentives. The document serves as a concise policy reference on benchmark, shared savings, and related payment mechanics rather than announcing a new CMS rule. It is distinct from previously published broad Medicare reform coverage because it centers on the structure of ACO payment models themselves.

CMS said on October 15, 2026 that it is offering resources and regulatory flexibilities tied to a declared public health emergency in Alabama and Florida. The notice also includes Marketplace enrollment relief, showing how federal health agencies can use administrative tools to respond quickly during emergencies. The item is politically relevant because it reflects executive branch implementation of healthcare policy in crisis conditions.

CMS announced $78 million for Texas on October 15, 2026 to support rural healthcare workforce development, chronic disease prevention, and facility upgrades. The investments are designed to help rural communities retain care locally by addressing provider shortages and infrastructure constraints that can limit access. In practical terms, the funding aims to keep essential services within reach for patients who might otherwise face longer travel or fewer options.

This reported investigation examines the legal and practical obstacles patients face when they try to limit or opt out of health-data sharing. It highlights how privacy rights can be difficult to exercise in practice because of fragmented rules, complex consent processes, and limited patient control over downstream data uses. The piece is materially relevant to healthcare law because it centers on the gap between formal privacy protections and real-world enforceability.

The October 15, 2026 MLN Connects newsletter highlights recent CMS program updates, including newly announced rural-health funding items and other Medicare Learning Network information relevant to public healthcare delivery. As a roundup newsletter, it serves as a consolidated update source rather than a single policy announcement. Because newsletters often aggregate items covered elsewhere, this carries a higher duplication risk than the state-specific announcements and rule materials.

CMS posted the October 2026 quarterly OPPS addendum updating hospital outpatient payment rates and APC assignments. The addendum is a core reference for hospitals, clinicians, and analysts tracking how Medicare will pay for outpatient services beginning in October 2026. It is materially focused on current outpatient payment rate files rather than broader payment policy proposals already covered in prior posts.

CMS announced a second year of savings from efforts to stop advance premium tax credit payments for Marketplace coverage tied to duplicate enrollments and deceased enrollees. The press release frames the action as an enrollment integrity measure intended to reduce improper federal spending in subsidized exchange coverage. This is materially distinct from prior enrollment totals, rulemaking, and open enrollment operations because it focuses on payment accuracy and removing ineligible subsidy payments.

DOJ announced indictments on October 13, 2026 in a remote IT worker conspiracy that affected more than 70 U.S. companies, including healthcare entities. The case underscores privacy and security risks tied to insider access, remote hiring, and unauthorized handling of company and potentially sensitive health-related data. For healthcare organizations, it highlights the importance of identity verification, access controls, and monitoring to reduce exposure from deceptive staffing schemes.

ASPR TRACIE updated its healthcare cybersecurity topic collection on October 9, 2026, bringing together current HHS and sector resources on cyber threats, ransomware preparedness, and protection of health information systems. For privacy-focused readers, the update is relevant because it consolidates practical material on reducing risks to sensitive health data and improving organizational readiness. The collection serves as a centralized reference point for healthcare entities reviewing cyber and information protection practices.

NIH announced an October 9, 2026 seminar focused on privacy-preserving genomic collaboration. The seminar highlights federated and cryptographic approaches that can support data sharing and reuse without exposing raw biomedical records, making it directly relevant to privacy, controlled access, and research governance. The event points to technical methods for balancing scientific collaboration with protections for sensitive genomic data.

CMS announced $209 million for rural Iowa to expand access to advanced medical care and strengthen rural service capacity. The funding includes maternal-fetal telehealth, specialty care expansion, advanced surgical capacity, cancer screening and prevention, EMS technology, and health information exchange improvements. CMS said the investment is intended to bring more complex and preventive care closer to patients in rural communities.

CMS announced $37.7 million for Louisiana to strengthen the rural healthcare workforce and improve access to care. According to the agency, the funding will support clinician recruitment and retention, partnerships between colleges and rural providers, and new healthcare career pathways. The investment focuses on building staffing capacity in rural areas where provider shortages can limit access.

CMS’s October 8, 2026 fact sheet outlines the 2027 Star Ratings for Medicare Advantage and Part D plans, a key quality measure used by beneficiaries when comparing coverage options. The update is distinct from prior posts because it focuses on plan performance ratings rather than drug price negotiation, ACO participation, or payment models. For Medicare enrollees, the ratings can affect plan choice during enrollment and reflect how plans performed on quality and service measures.

CMS announced more than $17 million for rural North Carolina through the Rural Health Transformation Program to expand behavioral health access. The funding supports new mental health clinics, mobile crisis teams, expanded addiction treatment including opioid treatment, and perinatal mental health services. The initiative is aimed at reducing gaps in crisis response and treatment availability in rural communities.

The Department of Veterans Affairs announced on October 7, 2026 a pilot program at six VA facilities intended to speed account setup and improve Veterans’ access to care, services, and benefits. This is materially different from the previously covered CMS-focused items because it concerns VA administrative access and service delivery rather than Medicare, Medicaid, or rural provider grants. The pilot could affect how quickly Veterans begin using VA programs after first contact with the system.

The Federal Register publication provides the official legal text of the final Transparency in Coverage rule, CMS-9882-F. As the formal rulemaking document, it sets out the regulatory amendments governing health plan transparency requirements and related implementation details. This source is materially distinct from a fact sheet because it serves as the primary legal publication for compliance and legal analysis.

CMS issued guidance for plan year 2027 on how the Marketplace should determine noncitizen eligibility for advance payments of the premium tax credit and cost-sharing reductions. The document addresses financial-assistance eligibility rules, verification and data matching issues, and how these determinations can affect reenrollment. This is materially different from previously published Marketplace notices because it focuses specifically on noncitizen subsidy eligibility administration for 2027.

A new KFF poll examines how healthcare is shaping voter attitudes ahead of the 2026 midterm elections, including views on healthcare costs, which party voters trust more on the issue, and support for Medicare-for-all. The findings add fresh public-opinion data to the political debate over healthcare, with implications for campaign messaging and issue priorities. Because this poll is specifically framed around the run-up to the 2026 election, it is materially distinct from earlier KFF polling already covered.

CMS posted the 2026 Federally-facilitated Exchange enrollment manual as an operational reference for Marketplace eligibility and enrollment processes in the federally facilitated Exchange. The manual covers procedures for applications, verification, redeterminations, special enrollment periods, and related case handling, making it a key source for assisters, issuers, and administrators working with Marketplace coverage. Because it is a technical operations document rather than a policy announcement or enrollment report, it is materially different from prior coverage on rulemaking and open enrollment snapshots.

CMS announced final changes to Transparency in Coverage rules intended to make healthcare prices and insurance coverage information easier for consumers to find, compare, and report. According to CMS, the rule strengthens disclosure of out-of-network payment information, improves access to personalized cost-sharing details, and standardizes data to support more usable pricing information. The update is framed as a cost-transparency measure aimed at helping patients better understand potential healthcare expenses.

The Justice Department announced an October 5, 2026 settlement resolving allegations that a Texas memory care facility discriminated against a National Guard medic in employment. The case highlights ethical obligations in healthcare workplaces to avoid discrimination tied to military service and to maintain fair treatment of employees. It also underscores federal enforcement aimed at institutional accountability when employment practices may violate civil rights protections.

CMS published a fact sheet explaining a one-time Medicare Part B premium rebate for certain Original Medicare beneficiaries. The FAQ format indicates the agency is clarifying eligibility and program administration details for beneficiaries and stakeholders. This is distinct from previously published Medicare payment and negotiation announcements because it centers on a direct premium rebate explanation.

CMS said it convened leaders of certified independent dispute resolution entities in October 2026 to discuss improvements to the federal program under the No Surprises Act. The meeting focused on administration of the dispute resolution process rather than a new rule or payment model. That makes it a distinct government-program management update within federal healthcare administration.

CMS announced $7.2 million in South Dakota Rural Health Transformation Program awards for ambulance-based telemedicine, EMS training, and emergency communications modernization. The funding is aimed at strengthening emergency response capacity in rural areas. This is materially different from previously published rural health funding stories because it focuses on South Dakota and emergency communications infrastructure.

In a report released October 1, 2026, HHS OIG said Medicare Advantage organizations and prescription drug plans paid $72 million over three years for services associated with excluded providers or individuals convicted of certain felonies. The report quantifies avoidable spending and highlights oversight gaps in screening and payment controls within Medicare Advantage and Part D. It adds a distinct cost angle beyond prior posts by focusing on improper payments tied to excluded or criminally disqualified actors.

CMS announced nearly $55 million in Rural Health Transformation Program funding for Alabama projects. The awards support rural maternal care, emergency medical services, cancer screening, and workforce development. This Alabama-specific funding package is distinct from previously published rural health awards for other states.

Sen. Cory Booker reintroduced the John Lewis EMMT Act on September 30 to require CMMI to include health-disparities expertise when developing Medicare and Medicaid payment models. The bill seeks to embed equity considerations directly into federal payment reform design rather than treating them as a separate policy track. It highlights an ongoing Democratic push to shape value-based care around disparities reduction.

CMS highlighted on September 30, 2026 how Texas employers are using CHOICE Arrangements and ICHRAs to offer workers a different path to coverage through the individual market or Medicare. The announcement emphasizes employer adoption and practical benefit design choices rather than the earlier Georgia-focused recognition of the model. It adds a new state-based implementation example with direct relevance for small employers evaluating coverage options.

CMS announced a final mandatory payment model for certain Medicare Part B drugs that uses international benchmark pricing. The agency said the model is intended to lower drug prices for beneficiaries in Original Medicare and marks a significant Medicare payment-policy change. As a finalized nationwide payment initiative, it is materially different from prior coverage on drug price negotiation and other Medicare program updates.

The Justice Department reported that Signal Diagnostics agreed to pay more than $20 million to resolve False Claims Act allegations tied to the HRSA Uninsured Program. According to the press-release listing, the allegations involved failure to refund overpayments, underscoring that healthcare entities can face major liability not only for initial billing conduct but also for retaining government funds after identifying overpayments. The matter reflects continuing federal attention to pandemic-era reimbursement programs and repayment obligations.

CMS announced $20 million for rural North Carolina investments in telehealth, healthcare technology, electronic health records, and cybersecurity. From a privacy perspective, the announcement highlights the need to secure patient data as providers expand digital infrastructure and remote care tools. The item is distinct in its focus on North Carolina and on technology upgrades tied to telehealth access.

The FDA released a discussion paper and request for feedback on possible regulatory approaches for generative AI-enabled medical devices. The agency is seeking public input on how existing medical device oversight may apply as generative AI features are incorporated into healthcare technologies. This is a notable healthcare law and policy development because it signals active federal consideration of how safety, effectiveness, and post-market oversight should work for AI-enabled devices.

The FDA updated its READI-Home Innovation Challenge page, which focuses on reducing readmissions through device innovation for home use. Although it is less directly legal than fraud or enforcement news, the initiative is relevant to healthcare governance because it shows the agency encouraging device development in an area tied to home-based care and hospital readmission policy. The page also reflects FDA interest in how oversight and innovation intersect in the home-health device space.

CMS announced $8.7 million for ambulance replacement and lifesaving medical equipment upgrades across rural Montana. While not an enforcement action, the announcement is relevant to law and governance because it concerns federal healthcare program implementation and the allocation of public funds for rural emergency medical infrastructure. It offers a window into how the administration is using federal health authorities and funding mechanisms to support rural care capacity.

Sens. Mark Warner and Bill Cassidy reintroduced bipartisan legislation on September 29 to expand federal drug acquisition cost surveys to specialty and mail-order pharmacies. The senators argue better reimbursement data would improve payment policy and help protect patients from higher out-of-pocket costs. The bill has implications for both Medicare and Medicaid drug reimbursement debates.

An HHS OIG report published September 28, 2026 found that many independent organ procurement organizations did not meet Medicare requirements for reporting kidney transportation costs, and some did not transport organs in line with Medicare rules. The findings raise cost-accountability concerns because Medicare reimbursement depends on accurate reporting and compliance with transportation requirements. This is distinct from previously published cost stories because it focuses on transplant logistics, reimbursement integrity, and oversight of a specialized provider type.

The reported Senate text for S. 5526 includes healthcare access provisions affecting rural and underserved communities. According to the bill text, the measure includes eligibility expansions touching mental and behavioral health facilities, health centers, and rural health clinics. Because it is legislative text rather than an agency announcement, the practical effects would depend on further congressional action.

CMS announced $169 million through the Colorado Rural Health Transformation Program to expand access to specialty care and strengthen emergency services in rural parts of the state. The funding also supports mobile and home-based care, blood transfusion capacity closer to patients, and behavioral, maternal, newborn, and pediatric services. The announcement focuses on Colorado-specific rural access investments and is materially distinct from prior coverage centered on New Mexico, Indiana, Medicaid drug payment models, and Medicare benefit options.

On September 25, 2026, CMS announced a multistate Medicaid quality initiative focused on health outcomes and said 37 states are participating in the effort. The announcement signals a federal policy shift in how Medicaid quality is measured and managed, with emphasis on state collaboration and outcome-based improvement. Because it centers on Medicaid policy direction rather than the already covered health care tax or organ procurement rulemakings, it stands apart as a distinct legislation-related development.

On September 25, 2026, the New York City Council announced a package of legislative proposals addressing potential risks of artificial intelligence. The measures include proposals tied to public safety and city operations, indicating possible effects on how municipal systems are governed and overseen. This is materially different from the previously covered state health care protections and federal health agency rule proposals because it concerns local AI legislation.

House and Senate Democrats introduced the No Surprise Bills for Seniors Act on September 24, aiming to shield Medicare Part D enrollees from losing drug coverage after unexpected premium increases. The measure focuses on a specific gap in beneficiary protections rather than broader surprise-billing policy. It adds to election-season pressure around prescription affordability and seniors’ coverage stability.

The Justice Department said a Florida doctor was sentenced for making false statements in connection with a multi-million-dollar healthcare fraud scheme. The announcement describes conduct tied to medically unnecessary genetic testing and durable medical equipment claims, showing continued criminal enforcement against providers linked to fraudulent federal healthcare billing. The case highlights legal exposure not only for submitting false claims, but also for false statements made during the scheme.

In a September 24, 2026 report, HHS OIG found limitations in CMS’s process for checking the accuracy of state-submitted Medicaid managed care medical loss ratio data. Because medical loss ratio reporting helps show whether capitation payments are being spent on patient care rather than administration or profit, weaknesses in CMS review can affect oversight of public spending. The report is materially distinct from prior posts because it focuses on data validation and fiscal accountability in managed care reporting, not broader Medicaid demonstration or state control policies.

This September 24, 2026 HHS OIG data brief examines how CMS’s price-substitution policy, using 2024 average sales prices, affected Medicare Part B drug payments. The brief is directly relevant to drug cost containment because it measures how payment substitutions changed Medicare spending for Part B drugs. It differs from earlier published items by focusing narrowly on the payment impact of a specific Part B pricing policy rather than broader Medicare reforms or beneficiary out-of-pocket costs.

CMS announced nearly $23 million for Delaware rural health centers to support electronic medical record upgrades, remote patient monitoring, care coordination, and cybersecurity improvements. The privacy significance lies in strengthening the security of digital health systems that handle patient information while expanding connected care. The funding links access improvements with more resilient data protection practices in rural healthcare settings.

Sen. Mark Warner unveiled a broad health reform bill on September 24 that would address ACA subsidies, a public option, Medicare drug pricing, Medicaid, PBM practices, and price transparency. The proposal is notable for bundling multiple long-running health policy debates into one legislative package. As introduced, it serves as a major Democratic marker on costs, coverage, and federal health program reform.

Sens. Ben Ray Luján and Tom Cotton announced bipartisan legislation on September 23 to change how Medicare coverage determinations are made. According to the release, the bill would set clearer timelines, increase transparency, and strengthen CMS oversight of the process. The proposal targets delays and administrative barriers that can affect whether beneficiaries receive needed care promptly.

The Justice Department announced a $1 million False Claims Act settlement with a skilled nursing company and two executives over allegations that the company billed Medicare and Massachusetts Medicaid for medically unnecessary skilled nursing rehabilitation therapy. According to the announcement, the government alleged the therapy was not reasonable or necessary for certain patients and that resulting claims were improperly submitted for payment. The case adds to federal and state enforcement scrutiny of billing practices in post-acute and long-term care.

CMS announced actions on September 22, 2026 to cancel unauthorized Marketplace enrollments and add integrity measures aimed at fraud, waste, and abuse in the federally facilitated Marketplace. The agency said the steps affect broker activity and are intended to strengthen consumer protections around enrollment. This is materially different from prior enrollment-count and rulemaking coverage because it focuses on program integrity and improper enrollment prevention.

This CMS fact sheet outlines operational anti-fraud controls for the Federal Marketplace, including restrictions on broker access, electronic consumer authorization, and stronger identity and application checks. The measures are relevant to privacy because they aim to reduce unauthorized use of personal data in enrollment and account changes. The document adds implementation detail beyond the related press announcement.

CMS announced preliminary 2027 Medicare payment rates for clinical laboratory services on September 21, 2026. The agency said the proposed rates would better align Medicare payments with private-payer prices under the clinical laboratory fee schedule and could save taxpayers an estimated $1 billion each year. The announcement focuses specifically on laboratory service pricing, making it distinct from broader previously covered Medicare payment and reform actions.

CMS highlighted CHOICE Arrangements as a mechanism that can help small employers fund individual coverage for workers. The announcement frames the policy as a way to expand private coverage options and improve benefits access for small businesses and their employees. This is distinct from prior Marketplace enrollment coverage because it focuses on employer-linked individual coverage financing rather than Exchange enrollment totals or rule updates.

FDA announced a direct final rule updating nonclinical testing terminology to remove references to animal testing and to recognize alternative methods. The change reflects an ethics-related shift in biomedical research governance by formally accommodating newer testing approaches within FDA regulations. It also signals continued federal support for methods intended to reduce reliance on animals in preclinical research.

CMS announced a $74 million investment through the Rural Health Transformation Program to expand specialty, maternal, behavioral, and chronic disease care across rural, frontier, and Tribal communities in New Mexico. The agency said the funding is intended to strengthen access to services in areas that often face provider shortages and long travel distances for care. The announcement is distinct from prior Indiana and general rural health coverage because it focuses specifically on New Mexico and a different funding package.

CMS announced participating states in the GENEROUS Medicaid drug payment model, which it said is designed to lower drug costs and improve access to critical medications for Medicaid beneficiaries. The initiative focuses on payment reform in Medicaid drug purchasing and is framed by CMS as a way to help vulnerable patients obtain needed treatments. The announcement is materially different from previously published rural and workforce-focused access items because it centers on prescription drug affordability and Medicaid policy.

CMS posted operational guidance on scheduled HealthCare.gov maintenance windows during the 2027 open enrollment period. The notice is relevant to consumer access because it identifies planned periods when system availability may be limited during enrollment season. It is materially different from previously published enrollment snapshots because it concerns Marketplace operations and access logistics rather than enrollment counts or policy rules.

Published on September 17, 2026, this peer-reviewed article examines how open health data can be governed across biomedical research, healthcare, and public health while addressing privacy, equity, and trust. It emphasizes controlled access and ethical governance as key mechanisms for balancing data sharing with protection of sensitive information. The paper contributes a cross-sector privacy framework relevant to researchers, health systems, and public health institutions.

An HHS OIG audit posted September 17, 2026 found that Methodist Hospital received at least $12.4 million in Medicare overpayments. The report says the hospital did not fully comply with Medicare billing requirements and recommends that it repay the overpaid amount and strengthen its billing-compliance controls. The findings raise legal and financial risk tied to federal healthcare program billing.

This HHS OIG inspection report, posted September 17, 2026, reviews whether North Carolina’s Medicaid Fraud Control Unit met federal standards for staffing, referrals, fiscal controls, and training. Unlike a fraud case or settlement, it focuses on oversight capacity and compliance infrastructure for investigating Medicaid fraud and patient abuse or neglect. The report is legally significant because it assesses whether a state enforcement unit is operating in line with program requirements.

CMS announced $167 million in Rural Health Transformation Program funding for South Carolina. CMS said the money will support telehealth, mobile care, health IT modernization, and improved maternal and behavioral health access. The funding is aimed at expanding service capacity and prevention efforts in rural communities.

CMS announced a $50 million Rural Health Transformation Program investment for Connecticut. The funding is intended to support rural hospital infrastructure, facility modernization, and access to care in local communities. The announcement frames the award as part of broader efforts to strengthen rural care delivery.

An HHS OIG report listed on September 16, 2026 concerns Medicare billing compliance at McLeod Regional Medical Center. The audit adds to federal scrutiny of whether hospitals are following Medicare provider billing rules and may expose repayment or corrective-action risk if noncompliance is identified. It is materially different from prior settlement stories because it centers on an audit of provider compliance rather than resolved fraud allegations.

Senate appropriators’ minority leaders Patty Murray and Tammy Baldwin said they are concerned the Trump administration may redirect or impound congressionally approved funding for the Agency for Healthcare Research and Quality. The release frames the dispute as an oversight and separation-of-powers conflict over healthcare research funding near the end of the fiscal year. It stands apart from the previously published items because it centers on congressional scrutiny of federal research dollars rather than program funding announcements or public opinion polling.

House Appropriations Democrats warned that the administration may withhold or divert healthcare research funding for AHRQ as the fiscal year deadline approaches. The statement presents the issue as a conflict between Congress and the executive branch over whether appropriated research money will be spent as lawmakers intended. This is a separate political oversight item from other published healthcare funding stories because it focuses on a partisan budget dispute over federal research support.

An FDA warning letter posted September 15, 2026 cites sterile-drug current good manufacturing practice violations at Bausch & Lomb’s Tampa facility. The letter signals potential patient-safety concerns and legal exposure if manufacturing deficiencies are not corrected. This is distinct from billing and fraud matters because it involves drug-manufacturing compliance under FDA regulatory authority.

CMS said it is expanding the ACCESS Model to Original Medicare and adding technology-supported care options for substance use disorder, heart failure, COPD, and tobacco cessation. The agency framed the change as a way to give Medicare enrollees more support managing common chronic conditions and accessing care outside traditional visit patterns. This is materially different from prior published items because it focuses on Medicare benefit design and chronic-condition management rather than rural transformation funding.

On September 15, 2026, the FTC announced that it withdrew its 2021 policy statement on breaches involving health apps and connected devices, describing that earlier statement as obsolete. The action signals a change in how the agency frames privacy and breach oversight for digital health technologies. For organizations handling sensitive health data outside traditional clinical settings, the move is a notable federal privacy development to watch.

The House-reported text of H.R. 9228, posted on GovInfo on September 15, 2026, addresses access to de-identified health-claims information by ERISA plan fiduciaries. The bill is legally notable because it concerns data access, transparency, and plan oversight rather than fraud enforcement, potentially affecting how employer health plans evaluate costs and administration. Its significance lies in proposed statutory changes, not an agency enforcement action.

A KFF survey published September 15, 2026 highlights affordability and access problems faced by adults with multiple or serious health conditions. The findings cover medical bills, delayed or skipped care, medication underuse due to cost, and insurance denials, offering a patient-experience view of cost pressures rather than a federal payment policy announcement. That makes it distinct from previously published CMS- and MedPAC-focused cost coverage.

The House Energy and Commerce Committee said its health subcommittee held a hearing on Medicare provider payment challenges and efforts to strengthen cybersecurity across the healthcare system. The hearing signals ongoing legislative attention to provider finances and digital security as healthcare policy priorities. It is materially different from the already published items because it covers congressional policy deliberations rather than agency funding awards, polling, or enforcement actions.

The Justice Department and HHS Office for Civil Rights announced a settlement with Lincoln Memorial University’s DeBusk College of Osteopathic Medicine over allegations of discrimination against Jewish students. The action centers on equal treatment, religious accommodation, and institutional accountability in a healthcare training setting. As an ethics-related development, it highlights federal enforcement expectations for nondiscrimination in medical education and student access.

CMS updated its CY 2027 guidance on Medicare Advantage and Part D enrollment and disenrollment policies. The document addresses eligibility, election periods, disenrollment rules, and when coverage becomes effective, making it a significant operational reference for Medicare coverage administration. It is materially different from Marketplace-focused items because it centers on Medicare plan enrollment rules rather than Exchange coverage.

CMS published a fast-facts document explaining Medicare provider enrollment moratoria and related oversight changes. While focused on provider enrollment integrity rather than beneficiary sign-ups, it is relevant to coverage administration because provider participation and program safeguards affect access and oversight within Medicare. The item is distinct from consumer enrollment notices and Marketplace reports because it addresses program integrity tools in Medicare enrollment policy.

A KFF survey found that adults with multiple or complex health conditions, especially uninsured people, report major problems affording care, paying for medications, and maintaining coverage. The findings point to persistent access barriers tied to cost as well as the added burden faced by people with greater health needs. This item is distinct from previously published policy announcements because it provides survey evidence about patient experiences rather than describing a government funding or payment initiative.

CMS announced more than $104 million in Rural Health Transformation Program funding for Mississippi. According to CMS, the award includes support for telehealth, diagnostic equipment, cybersecurity, and maternal and behavioral healthcare. The program is intended to bring more services closer to home for rural residents.

FDA posted a Pediatric Advisory Committee meeting announcement that engages ethical questions around protections for children in regulated therapies. The topic is relevant to consent and permission, safety oversight, and how institutions evaluate risks for pediatric populations. As an ethics post, it fits ongoing public-interest concerns about safeguards for vulnerable groups in medical regulation.

FDA published a meeting notice seeking public input on future medical device regulatory science. While the notice is broad, it is relevant to privacy because connected, software-driven, and sensor-based devices depend on governance for data handling within digital health systems. The agenda-setting process may influence how privacy and cybersecurity questions are addressed in device development and oversight.

WHO’s event page for the third meeting of the Global Initiative on AI for Health highlights privacy-preserving evaluation approaches that keep clinical data under institutional control while models are assessed securely. This is relevant to privacy because it points to governance and technical methods that reduce the need to centralize sensitive health data. The meeting suggests continued international interest in evaluating health AI without broad data sharing.

CMS announced nearly $17 million for Kansas through the Rural Health Transformation Program to support adoption of emerging health care technologies and improve patient transportation between facilities. The funding represents a distinct federal rural-health policy action with a state-specific focus. It differs from the already published titles, which centered on KFF polling about health care costs and the midterms.

CMS's 2026 transmittals page includes R13930CP, dated September 11, 2026, implementing FY 2027 Inpatient Prospective Payment System and Long-Term Care Hospital changes for Medicare administration. The posting points to routine program instructions used to operationalize payment and hospital policy updates. This is a Medicare administration item distinct from previously covered drug pricing and ACO announcements.

The Justice Department announced that an eye practice and its physician owner agreed to pay $350,000 to resolve allegations that they submitted false claims to Medicare. According to the announcement, the matter involves healthcare billing enforcement under the False Claims Act. The case is a smaller but distinct Medicare fraud settlement compared with previously covered large-scale healthcare fraud and kickback matters.

CMS published a September 2026 marketplace update page that includes a Medicaid and CHIP Coverage Data Matching Issue checklist. The page is relevant to eligibility and administrative coordination across public coverage programs, especially where data matching affects enrollment or case handling. It serves as an operational resource rather than a policy announcement.

The FTC updated its case page for an enforcement action alleging that a telehealth company shared sensitive health information with advertising platforms. The matter is notable for privacy because it centers on handling of health-related data in a consumer-facing digital care setting. It also signals continued regulator focus on how telehealth firms disclose, use, and share sensitive information for marketing and advertising purposes.

CMS announced $11.7 million in rural-health funding for Vermont aimed at expanding access, improving patient care facilities, and strengthening workforce capacity in nursing homes and the long-term care system. The announcement is a separate administration policy item focused on rural care infrastructure and staffing. It is materially different from previously published election-related polling coverage.

FDA announced a public meeting focused on the public health effects of opioid medications. The notice raises ethics questions about how agencies and manufacturers balance therapeutic benefits against widespread risks and downstream harms. It also points to broader issues of public duty, transparency, and accountability in medication oversight.

NIH announced policy changes aimed at strengthening accountability in hostile work environment investigations across NIH-funded research. The update is designed to prevent investigators from avoiding scrutiny by moving between institutions, while emphasizing due process and safer research settings. The ethics relevance centers on institutional responsibility, researcher conduct, and protections for people working in biomedical research environments.

CMS announced $4.8 million for West Virginia to strengthen the rural health care workforce and expand preventive care, including support tied to home dialysis access and transportation. The release presents a distinct federal health policy and funding development with implications for rural service delivery. It is separate from previously covered KFF polling on health care costs and midterm politics.

CMS announced enforcement actions against 11 medical equipment suppliers over suspected fraudulent Medicare Advantage and Part D billing totaling about $3.4 billion. The action highlights a major federal anti-fraud initiative in health care administration rather than a campaign or polling story. It is materially different from previously covered KFF election-focused health cost polling items.

A VA article says Indian Health Service leaders visited Indiana to review lessons from the Federal EHR deployment there before IHS begins its own rollout in late September. The piece highlights operational and clinical workflow observations from the Indiana go-live and frames them as preparation for IHS implementation. This is a public-program technology and care delivery update with implications for federal health system readiness.

VA Community Care states that, effective September 8, 2026, VA no longer requires precertification before providing authorized care for veterans. The update affects care coordination and administrative steps tied to authorized community care. For public-program participants and providers, the change signals a simplification of an access-related requirement.

CMS announced a $120 million award in Indiana aimed at expanding maternal and infant health services, increasing primary care access, and growing the health care workforce. The press release says the funding is also intended to reduce rural barriers to care, tying workforce and service expansion to access goals. The award stands out as a concrete state investment tied to multiple access-related needs at once.

DOJ announced a $541.5 million settlement with The Villages Health System LLC to resolve False Claims Act allegations related to diagnosis coding. The government alleged unsupported diagnoses inflated Medicare Advantage payments, raising compliance and documentation concerns. The settlement is notable for its size and for its implications for coding accuracy, reimbursement oversight, and standards affecting patient care records.

New Jersey Governor Sherrill announced the signing of state legislation strengthening protections for reproductive healthcare and gender-affirming care. The enacted law is presented as a state-level effort to protect access to these services and reinforce legal safeguards for patients and providers. As signed legislation rather than a proposal, it marks an immediate policy development in New Jersey.

This HHS-OCR regulatory plan outlines a forthcoming HIPAA Privacy Rule stage focused on individual access, care coordination, emergency disclosures, and related privacy-accountability tradeoffs. Ethically, it raises questions about how to balance patient privacy with timely information-sharing for treatment and emergencies. The plan is useful for tracking how federal policymakers frame competing obligations to autonomy, safety, and system responsibility in health information governance.

DOJ announced that Veloxis Pharmaceuticals agreed to pay more than $46 million to resolve criminal and civil allegations tied to kickback schemes involving prescriptions for a transplant drug. The resolution centers on alleged unlawful payments and federal healthcare program implications, with DOJ framing the case around program integrity and patient safety. The case underscores continued enforcement against pharmaceutical marketing practices that may influence prescribing.

CMS published a proposed Medicaid financing rule addressing the indirect hold harmless threshold for health care-related taxes under federal law. The fact sheet indicates the proposal would change how this threshold is applied in evaluating state tax arrangements tied to Medicaid financing. Because these rules can affect state funding structures, the proposal may have significant implications for state Medicaid policy and budgeting.

CMS released a proposed physician payment rule for 2026 that ties cost policy to broader payment reform, including accountable care incentives and updates to physician reimbursement. The agency says the proposal would help modernize payment while avoiding an estimated $2.38 billion in improper advanced alternative payment model incentive payments over 10 years. For cost watchers, the proposal is notable because it frames physician payment changes as both a budget issue and a lever for moving Medicare away from volume-driven care.

FDA requested input for its 2026 report on non-device software functions, covering areas such as electronic patient records and software that transfers or displays data. The request is privacy-relevant because these functions often involve the handling, movement, and presentation of sensitive patient information, even when they are not regulated as medical devices. It also highlights patient-safety implications tied to data management tools that sit outside traditional device oversight.

CMS proposed OPPS and ASC payment changes aimed at affordability for Medicare beneficiaries, with a focus on drug payment policy, site-of-care incentives, and lower out-of-pocket costs. The agency highlights 340B drug payment changes and projected savings for Medicare and taxpayers, alongside reforms intended to reduce incentives that can make hospital outpatient care more expensive. The proposal is significant on cost because it combines beneficiary affordability with federal savings and provider payment redesign.

CMS published the July 2026 Marketplace eligibility determination notice materials used in coverage, eligibility, and enrollment communications. The page provides access to template notices that explain decisions and next steps to applicants and enrollees. It is an operational communications resource rather than a policy announcement or enrollment report.

DOJ announced a nationwide healthcare fraud enforcement action charging 455 defendants in connection with more than $6.5 billion in alleged fraud. The announcement spans schemes involving healthcare fraud, opioid-related conduct, provider exclusions, and allegations of patient harm. It reflects the scale of federal enforcement and the legal risks facing providers, executives, and intermediaries across multiple parts of the healthcare system.

The Justice Department announced a proposed settlement requiring OhioHealth to stop using contract terms alleged to restrict competition. According to DOJ, the challenged terms raised healthcare costs for Ohio patients and employers by limiting insurers' ability to steer patients to lower-cost providers. The matter highlights antitrust scrutiny of healthcare contracting practices with downstream effects on prices and patient choice.

CMS issued guidance signaling tighter oversight of budget neutrality for Medicaid section 1115 demonstrations. The move centers on constraining how demonstration spending is measured and justified, with direct consequences for both federal and state Medicaid costs. This is a meaningful cost development because it could limit financing flexibility that states have used to support higher spending under waiver authority.

CMS issued an interim final rule with comment period to implement Medicaid community engagement requirements for certain adults. The fact sheet frames the policy as applying to specified individuals and outlines the federal rulemaking step taken in June 2026. Because eligibility and coverage conditions can affect access to care, the rule is a consequential change for Medicaid administration and beneficiaries.

CMS finalized changes to the No Surprises Act independent dispute resolution process that lower administrative fees and revise batching and transparency rules. While the rule mainly addresses insurer-provider payment disputes, its cost relevance lies in reducing administrative friction and fees tied to resolving out-of-network payment disagreements. The changes could affect system costs indirectly by altering how often disputes are filed and what they cost to pursue.

CMS proposed Medicaid managed-care financing and payment changes aimed at state directed payments, provider taxes, and spending growth. The agency says the proposal would curb financing practices it views as inflating federal Medicaid costs while tying payments more closely to quality. Cost implications are potentially large because the rule targets mechanisms many states use to raise provider payments and draw down federal funds.

This final federal rule addresses documentation standards for consumer consent in the Marketplace, making it relevant to ethical questions about informed consent, enrollment integrity, and administrative accountability. By clarifying what must be documented, the rule aims to reduce unauthorized or improper enrollments and strengthen oversight of entities handling consumer decisions. The ethics angle centers on whether healthcare administration practices adequately respect individual choice while maintaining trustworthy records and compliance.

CMS finalized its 2027 Payment Notice with lower Exchange user fees and other policy changes affecting individual-market affordability and oversight. The agency presents the rule as a cost-lowering measure that also addresses fraud and gives states more flexibility, with implications for premiums, administrative expenses, and coverage dynamics. For a cost-focused audience, the key issue is how marketplace fee and affordability policy can shape what enrollees and taxpayers pay.

This CMS fact sheet summarizes the final 2027 Marketplace payment notice and the standards it sets for Exchanges, insurers, brokers, and related coverage rules. It also covers final policies on hardship exemptions and other operational requirements affecting Marketplace coverage. The document reflects finalized federal policy rather than proposed changes.

A U.S. Attorney's Office announced a $15.2 million civil judgment resolving Medicaid fraud allegations involving operators of a children's day treatment program. The matter involves behavioral health services for children and includes a corporate integrity agreement and compliance obligations. The resolution highlights legal and oversight risks in pediatric Medicaid-funded care and the importance of program compliance.

This KFF poll focuses on how health care affordability is influencing voter preferences in the 2026 midterm cycle. It adds updated public opinion data on the political weight of health costs and the role the issue may play in electoral choices. The findings help explain why health care remains central in campaign strategy and policy messaging.

DOJ announced that the National Partnership of Insurance Brokers and its former subsidiary agreed to pay more than $135 million to resolve allegations involving an Affordable Care Act enrollment fraud scheme. The case concerns alleged misconduct affecting consumers and federal enrollment processes, with particular relevance to protections for vulnerable enrollees. It illustrates legal exposure for entities involved in insurance marketing and enrollment assistance.

ASTP/ONC’s HTI-3 Final Rule updates federal health IT policy on information blocking, including privacy-related changes. The rule adds a new Protecting Care Access Exception and revises provisions connected to reproductive health information, which is significant for how providers, developers, and health information networks handle sensitive data requests and disclosures. For privacy watchers, this is a notable regulatory development affecting access, permitted restrictions, and compliance expectations in electronic health information exchange.

CMS released public-use files for the 2026 Marketplace open enrollment period to support deeper analysis beyond national topline figures. The datasets can be used to examine state-level enrollment patterns, Medicaid and CHIP assessment activity, and Basic Health Program participation. This source is primarily a data release intended for public analysis and transparency.

CMS reported that 23.1 million people selected or were automatically re-enrolled in Marketplace coverage for 2026, describing exchange participation as near a record high. The release highlights continued use of financial assistance, relatively low out-of-pocket premium costs for many enrollees, and ongoing trends in plan affordability and cost-sharing support. It presents the 2026 results as evidence of continued Marketplace stability and strong consumer demand.

CMS said it held its first Rural Health Transformation Summit to support state-led work to strengthen rural health systems and expand access to care. The readout describes the summit as part of the agency’s rural transformation program and highlights collaboration with states on implementation and innovation. The announcement points to a federal effort focused on practical system changes in rural areas rather than only broad policy goals.

CMS’s rural health framework outlines how the agency plans to improve care in rural, Tribal, and geographically isolated communities. The page emphasizes health equity, identifies persistent access barriers, and describes CMS priorities for strengthening coverage, services, and care delivery in underserved areas. It serves as a policy overview for how the agency is approaching rural access challenges at a national level.

MedPAC’s March 2026 report to Congress reviews Medicare payment adequacy, beneficiary cost burdens, spending trends, and reform options across major payment systems. It provides a cross-cutting baseline for understanding where Medicare costs are rising, how payment rates compare with provider costs, and what policy changes lawmakers could consider. The report is especially useful for comparing cost pressures across hospital, physician, post-acute, and other sectors rather than focusing on a single CMS rule.

CMS announced stronger safeguards and oversight measures for the organ donation and procurement system, with a stated focus on patient protections and accountability. The guidance-centered action indicates closer scrutiny of how organ procurement organizations operate and are monitored. The changes are intended to reinforce standards in a system with significant consequences for patients awaiting transplants and donor families.

MACPAC’s March 2026 report includes analysis of Medicaid payment policy for the home- and community-based services workforce, linking payment rates to access and long-term spending pressures. Although narrower than a full program financing review, it addresses how states can use payment policy to stabilize care delivery and affordability in long-term services and supports. The report is relevant to cost because workforce payment decisions can influence both near-term Medicaid spending and the availability of less institutional care settings.

KFF reports that health care costs remain a salient political issue heading into the 2026 midterms, with the poll also testing reactions to expiring ACA tax credits. The findings highlight how voters view affordability pressures and which party they trust more on health issues. As a public opinion snapshot, the poll is relevant to campaign messaging and congressional debate over health policy.

CMS announced the proposed 2027 Notice of Benefit and Payment Parameters, outlining potential policy changes for ACA Marketplaces. The proposal addresses eligibility verification, subsidy administration, agent and broker conduct, and standardized plan options, with the stated goals of reducing costs and strengthening program integrity. Because it is a proposal, the release describes possible future rules rather than final requirements.

CMS reported growth in 2026 participation across Medicare Accountable Care Organization initiatives, including the Shared Savings Program and Innovation Center models. The fact sheet highlights participating organizations and the number of beneficiaries aligned to these initiatives. It provides a snapshot of the scale of Medicare’s value-based care programs heading into 2026.

This CMS fact sheet provides a national overview of 2026 open enrollment activity across HealthCare.gov and state-based exchanges. It summarizes plan selection totals and other high-level participation measures for the coverage year. The snapshot serves as a baseline federal summary of how the 2026 enrollment season unfolded nationwide.

FDA’s January 2026 final guidance clarifies which clinical decision support software functions are excluded from device regulation. While focused on regulatory scope, the guidance matters for privacy because it helps define oversight boundaries for software that uses, analyzes, or presents patient data in clinical settings. The document is relevant to ongoing questions about digital health data use, accountability, and when federal requirements attach to software functions handling sensitive health information.

CMS announced a proposed federal rule to tighten oversight of organ procurement organizations, including stronger recertification standards and performance accountability. The proposal is aimed at improving patient protections and the quality of organ recovery and transplantation services. If finalized, the rule would update how CMS evaluates OPOs and could affect certification status for organizations that fail to meet federal benchmarks.

CMS announced the 15 drugs selected for the third cycle of Medicare drug price negotiations for 2026, marking the first time the program includes Part B drugs. The selection expands the scope of Medicare price negotiation beyond earlier rounds that focused on Part D products. The announcement signals continued implementation of the negotiation program and identifies the products that will move into the next phase of the pricing process.